Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Chahrazed Bouzriba"'
Autor:
Atziri Corin Chavez Alvarez, Chahrazed Bouzriba, Emmanuel Moreau, Philippe Auzeloux, Sophie Besse, Vincent Ouellette, Mitra Zarifi Khosroshahi, Marie-France Côté, Sylvie Pilote, Elisabeth Miot-Noirault, Jean-Michel Chezal, Chantale Simard, René C -Gaudreault, Sébastien Fortin
Publikováno v:
Journal of Medicinal Chemistry. 66:2477-2497
Publikováno v:
Chemical biologydrug designREFERENCES. 99(2)
We prepared and biologically evaluated 32 novel molecules named phenyl 4-(dioxoimidazolidin-1-yl)benzenesulfonates (PID-SOs) and ethyl 2-(3-(4-(phenoxysulfonyl)phenyl)ureido)acetates (EPA-SOs). The antiproliferative activity of PID-SOs and EPA-SOs wa
Publikováno v:
Journal of Molecular Structure. 1259:132691
Publikováno v:
European journal of medicinal chemistry. 213
We recently designed and prepared new families of potent antimicrotubule agents designated as N-phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates (PIB–SOs) and phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonamides (PIB–SAs). Our previous structur
Autor:
Jacques Lacroix, Vincent Ouellette, Marie-France Côté, Chahrazed Bouzriba, Mathieu Gagné-Boulet, René C.-Gaudreault, Atziri Corin Chavez Alvarez, Sébastien Fortin
Publikováno v:
European Journal of Medicinal Chemistry. 229:114003
We recently discovered a new family of prodrugs deriving from phenyl 4-(2-oxo-3-imidazolidin-1-yl)benzenesulfonates (PIB–SOs) bioactivatable by cytochrome P450 1A1 (CYP1A1) into potent antimitotics referred to as phenyl 4-(2-oxo-3-alkylimidazolidin
Publikováno v:
European Journal of Medicinal Chemistry. 155:681-694
N-Phenyl ureidobenzenesulfonates (PUB-SOs) are a new class of anticancer agents blocking the cell cycle progression in S-phase, inducing replicative stress and DNA double-strand breaks (DSBs). In this study, we evaluate the effect of modifying the na
Autor:
Sébastien Fortin, Mathieu Gagné-Boulet, Chantale Simard, Atziri Corin Chavez Alvarez, Sylvie Pilote, René C.-Gaudreault, Chahrazed Bouzriba
Publikováno v:
Cancer Research. 81:1359-1359
Breast cancers (BC) are the most common cancers among women in North America. Several BC show high relapse rates or chemoresistance to current chemotherapies. Hence it is essential to develop new therapies to cure BC that would otherwise be lethal du
Publikováno v:
Cancer Research. 81:286-286
Cancer is still to this day one of the first causes of death in industrialized countries. Despite great progress made so far, there is still no treatment completely efficient and without toxicity. Therefore, the development of new anticancer drugs is
Autor:
Chahrazed Bouzriba, Atziri Corin Chavez Alvarez, Mathieu Gagné-Boulet, Sébastien Fortin, Marie-France Côté, René C.-Gaudrault, Jacques Lacroix
Publikováno v:
Cancer Research. 81:285-285
Enzyme-based prodrug treatments are innovative approaches that enable to convert a prodrug to a potent anticancer agent directly into the tumoral site. It is in this context that we recently discovered a new family of antimitotics that are CYP1A1-act
Autor:
Danny Lainé, Emilie Gillon, Chahrazed Bouzriba, Elena Shanina, Vincent Denavit, Denis Giguère, Christoph Rademacher, Sébastien Fortin, Anne Imberty
Publikováno v:
Chemistry-A European Journal
Chemistry-A European Journal, Wiley-VCH Verlag, 2019, 25 (17), pp.4478-4490. ⟨10.1002/chem.201806197⟩
Chemistry-A European Journal, 2019, 25 (17), pp.4478-4490. ⟨10.1002/chem.201806197⟩
Chemistry-A European Journal, Wiley-VCH Verlag, 2019, 25 (17), pp.4478-4490. ⟨10.1002/chem.201806197⟩
Chemistry-A European Journal, 2019, 25 (17), pp.4478-4490. ⟨10.1002/chem.201806197⟩
The replacement of hydroxyl groups by fluorine atoms on hexopyranoside scaffolds may allow access to invaluable tools for studying various biochemical processes. As part of ongoing activities toward the preparation of fluorinated carbohydrates, a sys
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ba3bbf6b9fcd98120e875dd1dc1af50
https://hal.archives-ouvertes.fr/hal-02104563
https://hal.archives-ouvertes.fr/hal-02104563